IL34 and Cirrhosis: However, there was no significant difference of serum IL-34 between HBV-cirrhosis patients and HCs (26.58 vs. 21.22, p > 0.05), nor between CHB patients and HCs (21.22 vs. 15.71, p > 0.05).